Effect on concentration (and cognitive function) by single ingestion of a test food
- Conditions
- Healthy subjects
- Registration Number
- JPRN-UMIN000033570
- Lead Sponsor
- HUMA R&D CORP
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 80
Not provided
1)Patients currently receiving any type of drug or outpatient treatment 2)Subjects who are currently receiving exercise or dietary therapy under the supervision of a physician. 3)Persons with a history or current or concurrent liver disease or serious renal, endocrine, cardiovascular, gastrointestinal, pulmonary, hematologic, or metabolic disease. 4)Patients with a history of drug or food allergy 5)Those who wish to do so during pregnancy, lactation, or the duration of the study. 6)Persons with serious or past brain diseases. 7)Subjects who have received blood donations or vaccinations within the previous 3 months or have scheduled them during the study period. 8)People who routinely consume health foods, supplements, and medicines that may affect concentration 9)Persons with a history of psychiatric disorders (e.g., depression), sleep disorders, or psychiatric disorders in the past. 10)Alcoholism, substance abuse, or substance abuse with treatment or a history of treatment. 11)Employees working during night shifts, etc. 12)Excessively irregular lifestyle such as eating or sleeping 13)Subjects who have participated in other clinical studies or have participated in other clinical studies within the previous 3 months. 14)Persons who are difficult to comply with the records of various surveys 15)Other than the above, the principal investigator judged that the subject was ineligible for the study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Cognitrax,Uchida Kraepelin test
- Secondary Outcome Measures
Name Time Method POMS2 shorter version,VAS questionnaire,Salivary marker